Streptococcus pyogenes structure

Moderate to severe uncomplicated skin and skin structure infections caused by Staphylococcus aureus or Streptococcus pyogenes. 2glV q 12 h 10... 

Skin and skin structure infections- Skin and skin structure infections, including abscesses, cellulitis, infected skin ulcers, and wound infections caused by S. aureus (including penicillinase-producing strains) Streptococcus pyogenes, group D streptococcus including . faecalis, Acinetobacter sp. including iA. calcoaceticus] Citrobactersp.] E. coli] Enterobacter cloacae, K. pneumoniae]... 

Compiicated skin and skin structure infections Caused by Staphyiococcus aureus (methicillin-susceptible strains only). Streptococcus pyogenes, E. coii, or Peptostreptococcus sp. 

Complicated skin and skin structure infections (SSSIs) For the treatment of complicated SSSIs caused by S. aureus (methicillin-susceptible and -resistant strains). Streptococcus pyogenes, or Streptococcus agalactiae. It has not been studied in the treatment of diabetic foot and decubitus ulcers. 

Arcus VL, Proft T, Sigrell JA, Baker HM, Fraser ID, Baker EN Conservation and variation in superantigen structure and activity highlighted by the three-dimensional structures of two new superantigens from Streptococcus pyogenes. 1 Mol Biol 2000 299 157-168. 

Azithromycin, an azalide macrolide antibiotic (500 mg p.o. as a single dose on day 1, followed by 250 mg daily on days 2 to 5 total accumulation dose is 1.5 g), is indicated in the treatment of acute bacterial exacerbations of chronic obstructive pulmonary disease caused by Haemophilus influenzae, Moraxella (Branhamella) catarrhalis, or Streptococcus pneumoniae mild community-acquired pneumonia caused by H. influenzae or S. pneumoniae uncomplicated skin and skin-structure infections caused by Staphylococcus aureus, Streptococcus pyogenes, or S. agalactiae second-line therapy of pharyngitis or tonsillitis caused by S. pyogenes and in nongonococcal urethritis or cervicitis caused by Chlamydia trachomatis. 

Quinupristin/dalfopristin is a streptogramin. Quinupristin inhibits the late phase of protein synthesis dalfopristin inhibits the early phase of protein synthesis. It is indicated in the treatment of serious or life-threatening infections associated with VREF treatment of complicated skin and skin-structure infections caused by Staphylococcus aureus (methicillin-susceptible) or Streptococcus pyogenes. 

A drug combination of the streptogramins, quinupristin and dalfopristin was approved for IV use in the treatment of infections caused by vancomycin-resistant Enterococcus faecium bacteremia as well as skin/skin structure infections caused by MRSAand methicillin-sensitive Streptococcus pyogenes. Certain strains of E. faecium are resistant to essentially all... 

A number of gram-positive bacteria, as well as gram-negative, contain cell surface hair-like projections termed fibrillae. In Streptococcus pyogenes bacteria, these structures are composed of protein and lipoteichoic acid complexes. The lipid portion of the lipoteichoic acid complex appears to be the ligand structure that binds to the complementary protein or glycoprotein host cell sites. Mycoplasma spp. and some filamentous bacteria are able to attach by their terminal of attachment structures to host cells, specifically epithelial cells [6,8]. 

Figure 6.3 Non-antibacterial macrolides reported in ref. 10 with an IC50 against Streptococcus pyogenes of greater than 64 tg mL . These structures have a blocking group preventing the interaction of the ribosome with the desosamine OH and amine groups.

---